Erica Denhoff / Icon Sportswire via Getty Images Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be used to fight bird flu. The biotech ...

as holiday demand and higher egg prices due to a nationwide bird-flu outbreak led to massive gains in profit and sales. The company reported fiscal second-quarter net income of $219.1 million ...

This announcement had a ripple effect across the tech sector: * Other major AI players like Microsoft and Alphabet (Google's parent company) also experienced declines, while Meta bucked the trend ...

Moderna stock (MRNA) fell over 9% on Wednesday, forfeiting most of its gains from Tuesday's session during a volatile week for the stock seen after the first reported bird flu death in the US ...

Plexi Images ... flu in the United States since 2024 and 67 since 2022," the CDC added. Moderna shares were up 12% at $47.50 in early-afternoon trading Tuesday. Despite the gain, the stock ...

are climbing in Tuesday's premarket trading as seasonal flu cases in the United States show a marked increase. Moderna's stock rose 3.4%, while CureVac's shares soared by 5%, extending gains from ...

UV Flu Technologies, Inc. engages in the research, development, manufacture, and sale of air purification systems and products primarily in the United States. Its flagship product is the ViraTech ...

CDC said the public risk remains low. Bird flu has severely impacted poultry farms and cattle herds across 16 states, marking the worst outbreak of its kind. Moderna, backed by $176 million from ...

Moderna Inc (NASDAQ:MRNA) stock is surging today ... Human Services Department to speed up the development of its bird flu vaccine, as the virus spreads rapidly throughout the country.

Moderna (MRNA) stock traded more than 12% higher on Tuesday following several headline events. Late Monday afternoon, the Louisiana Department of Health reported the first Bird Flu-related human ...

Moderna stock (MRNA) fell over 9% on Wednesday, forfeiting most of its gains from Tuesday's session during a volatile week for the stock seen after the first reported bird flu death in the ... (Photo ...

Moderna shares jumped more than 10% to lead S&P 500 gainers Tuesday, a day after the first bird-flu death was reported ... Despite the gain, the stock has lost more than half of its value over ...